Evelo is a Massachusetts-based biotechnology company that researches and develops oral medicines for the treatment of inflammatory diseases.
Business Model:
Revenue: $1.5M
Employees: 51-200
Address: 620 Memorial Drive
City: Cambridge
State: MA
Zip: 02139
Country: US
Evelo is a Massachusetts-based biotechnology company that researches and develops oral medicines for the treatment of inflammatory diseases.
Contact Phone:
+16178708281
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/9/2018
IPO Valuation:
$509M
Ticker Symbol:
EVLO
IPO Price:
$16/share
Amount Raised:
$85M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2015 | Series A | 1 | $35M |
Flagship Pioneering Flagship Pioneering Flagship Pioneering Flagship Pioneering |
4/2018 | IPO | $100M | 4/2018 | Venture Round | 1 | $47.5M |
Dementia Discovery Fund Dementia Discovery Fund Dementia Discovery Fund Dementia Discovery Fund |
7/2017 | Series B | 5 | $50M |
Mayo Clinic Ventures Flagship Pioneering GV Celgene Alexandria Venture Investments Flagship Pioneering Mayo Clinic Ventures Flagship Pioneering GV Celgene Alexandria Venture Investments Flagship Pioneering |
7/2019 | Post-IPO Debt | $45M |
Horizon Technology Finance K2 HealthVentures |
2/2018 | Series C | $81.5M | 1/2021 | Post-IPO Equity | $67.5M | 5/2022 | Post-IPO Equity | $79.2M | 12/2022 | Post-IPO Debt | 1 | $45M |
Horizon Technology Finance Corporation Horizon Technology Finance |
---|
Announced Date | Name | Price |
---|---|---|
7/2016 | Epiva |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|